KHOSLA CHAITAN PHD 4
4 · Protagonist Therapeutics, Inc · Filed Apr 8, 2020
Insider Transaction Report
Form 4
KHOSLA CHAITAN PHD
Director
Transactions
- Award
Stock Option (right to buy)
2019-08-15+5,000→ 5,000 totalExercise: $9.99From: 2019-08-15Exp: 2029-08-14→ Common Stock (5,000 underlying)